Sionna Therapeutics is a biotechnology company developing medicines for cystic fibrosis. Its programs focus on restoring normal function of the CFTR protein through modulators and complementary approaches targeting underlying defects.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!